Comparative immunogenicity and protective efficacy of BECC438 and BECC470 adjuvants in a vaccine formulation against Pseudomonas aeruginosa
The development of effective vaccines against the opportunistic pathogen Pseudomonas aeruginosa (Pa) remains a critical public health priority for susceptible individuals due, in part, to the pathogen’s intrinsic resistance mechanisms. This study evalu…